- ►annals.org [PDF] L Fuccio, ME Minardi, RM Zagari, D Grilli, N … - Annals of Internal Medicine, 2007 - Am Coll Physicians Background: Proton-pump inhibitor (PPI)–based triple therapy is the
recommended first-line treatment for Helicobacter pylori infec- tion. A
consensus on treatment duration is lacking. ... Purpose: To summarize the ... Cited by 26 - Related articles - BL Direct - All 5 versions
A Zullo, V De Francesco, C Hassan, S Morini, … - British Medical Journal, 2007 - gut.bmj.com Background:: Standard triple therapies are the most used treatment in clinical
practice. However, a critical fall in the H pylori eradication rate following
these therapies has been observed in the last few years. The sequential ... Cited by 40 - Related articles - BL Direct - All 5 versions
L Fischbach, EL Evans - Alimentary Pharmacology and Therapeutics, 2007 - mp.medscape.com Over 50% of the global population is infected with Helicobacter pylori, [1,2]
and in many adult populations in developing countries, the prevalence can be
over 90%. [3,4] To combat this global disease, the latest Maastricht ... Cited by 26 - Related articles - BL Direct - All 13 versions
[CITATION] Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for
- ►annals.org [PDF] NS Jafri, CA Hornung, CW Howden - Annals of internal medicine, 2008 - Am Coll Physicians Page 1. Meta-analysis: Sequential Therapy Appears Superior to Standard Therapy
for Helicobacter pylori Infection in Patients Naive to Treatment ... Cited by 34 - Related articles - BL Direct - All 6 versions
RM Zagari, G Bianchi-Porro, R Fiocca, G … - British Medical Journal, 2007 - gut.bmj.com Methods: A total of 909 H pylori-positive patients with duodenal ulcer, enrolled
in 81 endoscopy units in Italy, were randomised to receive omeprazole,
amoxicillin and clarithromycin for either 1 week (OAC1W) or 2 weeks (OAC2W) ... Cited by 29 - Related articles - BL Direct - All 5 versions
N Vakil, D Vaira - JAMA, 2008 - Am Med Assoc A less frequently used regimen is quadruple therapy, consisting of bismuth plus
metronidazole, tetracycline, and a PPI administered for 10 days. It has been
suggested as an alternative to PPI triple therapy. The most recent US study ... Cited by 7 - Related articles - All 2 versions
S Padol, Y Yuan, M Thabane, IT Padol, RH …, 2006 - nature.com When all eradication rates, regardless of PPI used, were combined there was no
significant difference between poor metabolizers (PM) and heterozygous extensive
metabolizers (HetEMs) (odds ratio [OR] = 1.35, 95% confidence interval [CI] ... Cited by 43 - Related articles - BL Direct - All 5 versions
S Miehlke, W Schneider-Brachert, C Kirsch, A … - HELICOBACTER-CAMBRIDGE USA-, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 19 - Related articles - BL Direct - All 3 versions
